These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26427585)

  • 1. Acute liver failure during hepatitis C treatment with sofosbuvir and ledipasvir.
    Debes JD; Ricci P
    Dig Liver Dis; 2015 Dec; 47(12):1091-2. PubMed ID: 26427585
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes in a Hepatitis C and HIV-Coinfected Patient Treated With the Ledipasvir and Sofosbuvir Regimen.
    Bhatti Z; Norsworthy J; Sivalingam D
    Am J Ther; 2018; 25(3):e391. PubMed ID: 29723164
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis.
    Rezaee-Zavareh MS; Hesamizadeh K; Behnava B; Alavian SM; Gholami-Fesharaki M; Sharafi H
    Ann Hepatol; 2017; 16(2):188-197. PubMed ID: 28233739
    [No Abstract]   [Full Text] [Related]  

  • 4. Sofosbuvir plus ledipasvir in combination for the treatment of hepatitis C infection.
    Bourlière M; Adhoute X; Ansaldi C; Oules V; Benali S; Portal I; Castellani P; Halfon P
    Expert Rev Gastroenterol Hepatol; 2015; 9(12):1483-94. PubMed ID: 26595560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of chronic inflammatory demyelinating polyneuropathy after hepatitis C virus eradication with sofosbuvir and ledipasvir therapy.
    Tsuzaki K; Someda H; Inoue M; Tachibana N; Hamano T
    Muscle Nerve; 2018 Nov; 58(5):E34-E36. PubMed ID: 30028899
    [No Abstract]   [Full Text] [Related]  

  • 6. Ventricular Tachycardia as a Complication of Ledipasvir and Sofosbuvir Treatment for HCV Infection.
    Nirei K; Nakamura H; Matsuoka S; Yamana Y; Yoda S; Hirayama A; Moriyama M
    Intern Med; 2017; 56(7):787-790. PubMed ID: 28381744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of sexually acquired acute HCV reinfection with ledipasvir/sofosbuvir in a HIV-infected patient.
    Sollima S; Antinori S; Torre A; Binda F; Giacomelli A; Milazzo L
    Int J STD AIDS; 2017 Jul; 28(8):838-840. PubMed ID: 28632109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging options for treating hepatitis C infection.
    Fantasia HC
    Nurs Womens Health; 2015; 19(2):183-7. PubMed ID: 25900589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harvoni (ledipasvir and sofosbuvir) for hepatitis C.
    Mullins C; Gibson W; Klibanov OM
    Nurse Pract; 2015 Nov; 40(11):22-6. PubMed ID: 26474199
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.
    Shah AP; Cameron A; Singh P; Frank AM; Fenkel JM
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28060446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity and potential drug interaction with ledipasvir/sofosbuvir in HIV/HCV infected patients.
    Tseng A; Wong DK
    J Hepatol; 2016 Sep; 65(3):651-3. PubMed ID: 27210428
    [No Abstract]   [Full Text] [Related]  

  • 12. A combination of ledipasvir and sofosbuvir (Harvoni) for hepatitis C.
    Med Lett Drugs Ther; 2014 Nov; 56(1455):111-2. PubMed ID: 25372848
    [No Abstract]   [Full Text] [Related]  

  • 13. Sexual Dysfunction in a Patient Taking Ledipasvir/Sofosbuvir for the Treatment of Hepatitis C: A Case Report.
    Lenz DU; Crutcher EL; Greene EM
    J Pharm Pract; 2019 Apr; 32(2):231-235. PubMed ID: 29183252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of the Treatment of Chronic Hepatitis C Virus Infection Genotype 2 by the Combination Sofosbuvir/Ledipasvir in a Black African Kidney Transplant.
    Lawson-Ananissoh LM; Anzouan-Kacou YHK; Tsevi YM; Ackoundou-N'Guessan KC; Attia KA
    West Afr J Med; 2019; 36(3):280-282. PubMed ID: 31622492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C in Persons With Sickle Cell Disease.
    Moon J; Hyland RH; Zhang F; Brainard DM; Lanzkron S; McHutchison JG; Sulkowski M
    Clin Infect Dis; 2017 Sep; 65(5):864-866. PubMed ID: 28505305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eight Weeks Treatment With Sofosbuvir/Ledipasvir in a 4-year-old Child With Chronic Hepatitis C Virus Genotype 1 Infection.
    Graf Einsiedel H; Christiansen H; Wiegand J
    Pediatr Infect Dis J; 2016 Dec; 35(12):1373. PubMed ID: 27832030
    [No Abstract]   [Full Text] [Related]  

  • 17. Occurrence and recurrence of hepatocellular carcinoma in patients with HCV genotype 1b related cirrhosis treated with Ledipasvir + Sofosbuvir ± Ribavirin.
    Pop CS; Preda CM; Manuc M; Gheorghe LS; Istratescu D; Chifulescu AE; Voiosu T; Diculescu M; Tieranu C; Iliescu L
    J Gastrointestin Liver Dis; 2020 Dec; 29(4):690-691. PubMed ID: 33331348
    [No Abstract]   [Full Text] [Related]  

  • 18. Perioperative Ledipasvir-Sofosbuvir for HCV in Liver-Transplant Recipients.
    Levitsky J; Verna EC; O'Leary JG; Bzowej NH; Moonka DK; Hyland RH; Arterburn S; Dvory-Sobol H; Brainard DM; McHutchison JG; Terrault NA
    N Engl J Med; 2016 Nov; 375(21):2106-2108. PubMed ID: 27959735
    [No Abstract]   [Full Text] [Related]  

  • 19. Myo-pericarditis secondary to ledipasvir-sofosbuvir therapy.
    Padegimas A; Forde KA; Goldberg LR; Birati EY
    J Hepatol; 2016 May; 64(5):1196-1198. PubMed ID: 26809114
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute Renal Failure in a Patient on Ledipasvir-Sofosbuvir Therapy for Hepatitis C.
    Chugh S; Solanki S; Singh J; Wolf DC; Chander PN
    Am J Ther; 2020 Jul; 28(6):e755-e757. PubMed ID: 32759622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.